Clinical importance of anti-Ro52 antibody for polymyositis and dermatomyositis.
Toshiki SugitaHiroto TsuboiNaoki SugitaRai AkiyoshiYuki KurodaAkira KawashimaFumina KawashimaDaiki TabuchiFumika HondaAyako OhyamaSaori AbeAyako KitadaHiromitsu AsashimaHaruka MikiShinya HagiwaraYuya KondoIsao MatsumotoPublished in: Modern rheumatology (2024)
Anti-Ro52 Ab were frequently positive in PM/DM and anti-Ro52 Ab-positive patients showed significantly higher rates of anti-ARS Ab positivity and ILD, GC-resistant cardiomyopathy, concomitant use of immunosuppressants, and higher levels of CRP. Anti-Ro52 Ab may be useful as a severity marker in PM/DM.